KUTRRH achieved another significant milestone with the launch of the formulary list by the KUTRRH CEO, Mr. Ahmed Dagane, on 3rd Aug 2022.
The process involved selecting drugs based on clinical and cost-effectiveness scientific evidence. Various sub-committees developed the formulary list under the medicines and therapeutics committee, which comprised clinicians, pharmacists, nutritionists, and other cadres under multiple specialties and subspecialties.
The formulary list will ensure the presence of safe and cost-effective medicines in the hospital and optimal drug budget utilization by reducing the high costs of handling a large number of drugs.